Vésale Pharma is a Namur-based company and a pioneer in the field of probiotics. Since 1996, the company has been developing, manufacturing and marketing probiotic solutions based on the latest scientific discoveries. Proprietor of several strains and patents, Vésale Pharma markets a wide range of products in the digestive, pediatric, immune and women’s health fields.
Thanks to rigorous selection of the probiotic strains used in its products, and a patented encapsulation process (Intelicaps) that enables probiotic strains to retain their metabolic activity, Vésale Pharma clearly stands out from the competition.
2 new departments were created in 2023 with Superbiotics, selling probiotics in bulk and also in animal health.
Its products are currently marketed in Europe, the US, Asia and the Middle East through a network of distributors, and in Belux through pharmacies and parapharmacies.
Vésale Pharma is born
In 2012, Vésale Pharma patented a probiotic micro-encapsulation process (Intelicaps®) that protects probiotics from humidity and heat. The process also protects bacteria from gastric acid and pancreatic juice without altering their functionality.
In June 2016, Vésale Pharma inaugurated a new production unit coupled with its R&D activities in Ghlin.
Creation of Vésale Bioscience, a spin-out of Vésale Pharma, dedicated to Phagotherapy
In 2022, Vésale Pharma will pursue its research activities in 3 areas (women’s health, digestive health and pediatrics), bringing new products to market as early as 2022.
R&D-based sales strategy
Vésale Pharma therefore relies on the development of innovative products to remain competitive. The products marketed by Vésale Pharma have the following characteristics:
Unlike suppliers of large probiotic solutions, Vésale has the flexibility (“agility”) to rapidly adapt the composition and galenic form of its products (capsules, sachets, oro-soluble powder, tablets, chewable tablets or liquid form) to enable them to be administered to every member of the family (including pregnant women).